China News Service, Shanghai, March 18 (Reporter Chen Jing) March 18 is the 22nd “National Liver Love Day”, Meng Chao Cancer Hospital Affiliated to Shanghai University Zhang Shaogeng, business director and director of surgical oncology, pointed out in an interview on the 18th that if liver cancer patients can be detected at an early or very early stage and receive radical treatment, the 5-year survival rate can be significantly improved, and the impact of liver cancer on the patient’s family can be greatly reduced. s damage.
The director of the first department of oncology, Lou Jinxing, said: “In view of the characteristics of liver cancer, which has many causes, high incidence, many patients with middle and advanced stages at the time of diagnosis, limited treatment methods, and high mortality, more experts are currently Pay attention to immunotherapy.” Lou Jinxing introduced that the decline or damage of the human immune cell function will cause the immune function to weaken, and cancer cells will take advantage of the weakness to form malignant tumors. “Therefore, helping the human body to improve its immunity and using its own immune cells as a ‘sword’ to kill tumor cells in the body is the focus of scientists and medical scientists at present.” He said that reactivating immune cells and enhancing their activity , which is what the people say to enhance the body’s “immunity”. If targeting and chemotherapy are compared to the “exorcism” of traditional Chinese medicine, then immunotherapy is “righteousness”.
It is reported that the theme of this year’s Liver Love Day is: public participation, active screening, standardized diagnosis and treatment, and cure of hepatitis. It is reported that Chinese patients with liver disease include hepatitis B, hepatitis C, excessive drinking, and non-alcoholic fatty liver disease.
In the popular science lecture of Mengchao Cancer Hospital Affiliated to Shanghai University, Zhang Shaogeng, Lou Jinxing, director of the First Department of Oncology, and Ren Yongqiang, director of the Health Management Center, focused on the topic of liver disease prevention and treatment, and popularized hepatitis, especially chronic viral hepatitis (hepatitis B). , hepatitis C) prevention and control knowledge, and pointed out that early screening and early diagnosis, standardized treatment, can effectively prevent hepatitis and its complications.
“Liver disease can only be cured if not prevented, and the more it is cured, the more busy it will be.” Ren Yongqiang pointed out: “To reduce the risk of cancer, we must do both ‘prevention’ and ‘treatment’. Both are indispensable.” Ren Yongqiang told reporters that at this stage, there are mainly two methods for early screening of liver cancer: B-ultrasound and tumor marker testing. . Usually, liver tumors larger than 1 centimeter can be detected by ultrasound, he said. He suggested that for high-risk groups of liver cancer such as a history of hepatitis, alcoholism, and non-alcoholic fatty liver disease, it is best to perform tumor screening every 3 to 6 months, and non-high-risk groups should also undergo annual tumor screening.
In the Clinical Research Institute of the Third Affiliated Hospital of Naval Military Medical University, the reporter saw that the hospital displayed photos of Wu Mengchao, an academician of the Chinese Academy of Sciences, when they participated in free clinics, consultations, and medical treatment for patients through pictures. Professor Yang Jiamei of the hospital called on the public to pay attention to and control fatty liver, and reminded the public that indicators such as age > 50 years, obesity (especially visceral obesity), hypertension, and type 2 diabetes are nonalcoholic steatohepatitis and progressive liver fibrosis. risk factors for .
Professor Zhou Weiping said that liver cancer resection is the main method to cure liver cancer. The 5-year survival rate of early stage liver cancer exceeds 70%, but the high recurrence rate after liver cancer surgery is also a bottleneck hindering the long-term prognosis of liver cancer resection. Therefore, regular follow-up and recurrence monitoring after resection is very important, and this is easily overlooked by patients, he pointed out. Professor Zhou Weiping told reporters that when he explained the postoperative precautions to discharged liver cancer patients and their families, he would instruct them to adhere to regular review, to detect possible recurrence of liver cancer as soon as possible, and to maintain close follow-up and contact with the surgical team. . (End)